Watkins Tim - Insider Non-Derivative Transactions at Contineum Therapeutics, Inc. (CTNM) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 29, 2025, Watkins Tim's relationship to Contineum Therapeutics, Inc. (CTNM) is Officer (CMO & Head of Development), and currently has 3,611 shares of Class A Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CTNM insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Watkins Tim - Insider Non-Derivative Transactions of CTNM Class A Common Stock

Watkins Tim - Insider Non-Derivative Transactions at CTNM

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 30, 2025	Sell -- (Class A Common Stock)	3611	12.06	0
Dec 30, 2025	M -- (Class A Common Stock)	3611	4.5	3611